A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone
Clinical trial NCT05971940 · COMPLETED
Trial details
- NCT number
- NCT05971940
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-09
- Primary completion
- 2025-04-03
- Enrollment
- 559
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.